PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models ...

Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...

The 3D human breast organoid model represents state-of-the-art technology that "floats" patient-derived or stem cell-derived human breast tissue in a gel-like substance known as the matrix. The model ...

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

The 3D Ready ™ Organoid Expansion Service offers researchers a huge quantity of high-quality, low-variability organoids in an assay-ready configuration. Molecular Devices recognizes the difficulties ...

Organoids, which are 3D cell cultures derived from stem cells, present new opportunities for personalized cancer treatment and precision medicine. However, the absence of a tumor microenvironment (TME ...

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons, which leads to nigrostriatal impairment. Although induced pluripotent stem cell (iPSC ...

Creative Biolabs is proud to announce an upcoming industry webinar on engineered human 3D brain tissues for neurodegenerative disease modeling.

The 3D human breast organoid model represents state-of-the-art technology that “floats” patient-derived or stem cell-derived human breast tissue in a gel-like substance known as the matrix. The model ...